Litcius/Paper detail

The Novel GlycoPEGylated FGF21 Analog Pegozafermin Activates Human FGF Receptors and Improves Metabolic and Liver Outcomes in Diabetic Monkeys and Healthy Human Volunteers

Moti Rosenstock, Leo Tseng, Andrew L. Pierce, Elliot Offman, Chaoyin Chen, R. Will Charlton, Maya Margalit, Hank Mansbach

2023Journal of Pharmacology and Experimental Therapeutics27 citationsDOIOpen Access PDF

Topics & Concepts

FGF21EndocrinologyInternal medicineAdiponectinMedicineHypertriglyceridemiaSteatohepatitisGlycated hemoglobinLipid metabolismGlucose homeostasisDiabetes mellitusInsulin resistanceFatty liverTriglycerideReceptorCholesterolFibroblast growth factorType 2 diabetesDiseaseFibroblast Growth Factor ResearchEpigenetics and DNA MethylationKruppel-like factors research
The Novel GlycoPEGylated FGF21 Analog Pegozafermin Activates Human FGF Receptors and Improves Metabolic and Liver Outcomes in Diabetic Monkeys and Healthy Human Volunteers | Litcius